| Critica Limited (CRI) ORDINARY FULLY PAID |
Materials |
$54 |
Critica Advances Jupiter- Outstanding Magnet and HREO Grades
|
16 Jul 2025 9:08AM |
$0.017 |
$0.020 |
risen by
17.65%
|
|
CRI - Price-sensitive ASX Announcement
Full Release
Key Points
- Critica Limited announced outstanding MagREO and HREO grades from the Jupiter project in Northern Territory.
- New drilling expanded high-grade rare earth mineralization, confirming Jupiter's significance.
- Key drill results demonstrate high total rare earth oxide grades over broad intervals.
- Significant concentrations of neodymium, praseodymium, dysprosium, and terbium reported.
- Jupiter project positioned as one of Australia’s largest rare earth discoveries.
- Ongoing resource definition drilling and metallurgical studies planned.
- Results solidify Critica Limited’s role in the rare earth supply chain.
- Further drilling and studies will assess economic potential and development options.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prescient Therapeutics Limited (PTX) ORDINARY FULLY PAID |
Health Care |
$43 |
PTX Opens First U.S. Site for PTX-100 Phase 2a Trial
|
16 Jul 2025 9:08AM |
$0.042 |
$0.041 |
fallen by
2.38%
|
|
PTX - Price-sensitive ASX Announcement
Full Release
Key Points
- Prescient Therapeutics Limited (PTX) has opened its first U.S. clinical site for the PTX-100 Phase 2a trial.
- PTX-100 is a novel inhibitor targeting geranylgeranyl transferase-1 (GGT-1).
- The Phase 2a trial focuses on patients with relapsed and refractory T cell lymphomas (PTCL and CTCL).
- Expansion into the U.S. enables broader patient access and collaboration with leading clinical centers.
- Previous trial cohorts showed promising efficacy and an encouraging safety profile.
- The initiative addresses unmet needs for patients with limited treatment options.
- PTX continues to advance innovation in cancer therapeutics through this clinical development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$11 |
Proposed issue of securities - DAL
|
16 Jul 2025 9:07AM |
$0.029 |
$0.039 |
risen by
34.48%
|
|
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$11 |
Proposed issue of securities - DAL
|
16 Jul 2025 9:07AM |
$0.029 |
$0.039 |
risen by
34.48%
|
|
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$11 |
Strategic Capital Raise With Cornerstone Support Completed
|
16 Jul 2025 9:07AM |
$0.029 |
$0.039 |
risen by
34.48%
|
|
DAL - Price-sensitive ASX Announcement
Full Release
Key Points
- Dalaroo Metals Ltd completed a $1.35 million capital raise at $0.045 per share.
- The raise was strongly supported by cornerstone investors and existing shareholders.
- Demand for the capital raise was significantly oversubscribed.
- Funds will be used for exploration at Browns Range, Lyons River, and Namban projects.
- The projects target critical minerals, including niobium, rare earth elements, and lithium.
- The company is actively reviewing further critical minerals project opportunities.
- Dalaroo expressed thanks to investors and reaffirmed its commitment to shareholder value.
- The announcement details the anticipated timeline for share issuance and new capital structure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$319 |
NTA at 11.07.25 Pre-tax 140.5 Post-tax 135.63
|
16 Jul 2025 9:05AM |
$1.205 |
$1.240 |
risen by
2.90%
|
|
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$16 |
Notification of cessation of securities - WNX
|
16 Jul 2025 9:04AM |
$0.255 |
$0.230 |
fallen by
9.80%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$646 |
Update - Notification of buy-back - RF1
|
16 Jul 2025 9:03AM |
$2.990 |
$3.030 |
risen by
1.34%
|
|
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$66 |
Radiopharm Receives $4.5M R&D Tax Incentive
|
16 Jul 2025 9:01AM |
$0.022 |
$0.028 |
risen by
27.27%
|
|
| Kingsgate Consolidated Limited (KCN) ORDINARY FULLY PAID |
Materials |
$737 |
Continued Exploration Success at the Chatree Gold Mine
|
16 Jul 2025 9:00AM |
$2.470 |
$2.860 |
risen by
15.79%
|
|
KCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingsgate Consolidated Limited reports continued exploration success at the Chatree Gold Mine.
- Recent drilling has delivered significant gold intersections and identified high-grade zones.
- These results are expected to increase resources, reserves, and potentially extend mine life.
- Active exploration is ongoing both near the mine and in regional targets.
- Refurbishment of the processing plant is progressing, supporting the restart of operations.
- The company is engaging with local communities and complying with regulatory requirements.
- Kingsgate remains optimistic about the long-term potential and growth of the Chatree Gold Mine.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vection Technologies Ltd (VR1) ORDINARY FULLY PAID |
Information Technology |
$98 |
Amendment - Vection Secures Further $0.5m Defence Order
|
16 Jul 2025 8:57AM |
$0.037 |
$0.054 |
risen by
45.95%
|
|
VR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Vection Technologies Ltd secured a further $0.5 million order from a defence sector client.
- The order is related to advanced 3D and VR technology solutions.
- This announcement amends details from an earlier release.
- The contract underscores Vection’s role as a strategic partner for the defence customer.
- The new order reflects growing demand for Vection’s immersive technology.
- The company demonstrates ability to scale and secure repeat business with key clients.
- This development supports Vection Technologies Ltd’s ongoing growth in the defence sector.
- The company continues to strengthen relationships in the immersive technology and defence markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cyclopharm Limited (CYC) ORDINARY FULLY PAID |
Health Care |
$109 |
CYC Appoints US Sales Vice President
|
16 Jul 2025 8:56AM |
$0.990 |
$0.985 |
fallen by
0.51%
|
|
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$359 |
Update - Notification of buy-back - PE1
|
16 Jul 2025 8:55AM |
$1.175 |
$1.305 |
risen by
11.06%
|
|
| Visionflex Group Limited (VFX) ORDINARY FULLY PAID |
Health Care |
$7 |
Webinar - Q4 FY25 Quarterly Activities Presentation
|
16 Jul 2025 8:55AM |
$0.003 |
$0.002 |
fallen by
20%
|
|
| Phoslock Environmental Technologies Limited (PET) ORDINARY FULLY PAID |
Industrials |
$6 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
16 Jul 2025 8:55AM |
$0.025 |
$0.009 |
fallen by
64%
|
|
PET - Price-sensitive ASX Announcement
Full Release
Key Points
- PET focused on operational improvements and cost-saving measures during the quarter.
- The company advanced business development opportunities in Europe and North America.
- Receipts from customers were received, and cash outflows were managed carefully.
- Phoslock product remains central to PET's environmental remediation strategy.
- Regulatory and technical progress was made to support new and existing projects.
- Ongoing monitoring of the situation in China and its impact on business.
- PET confirmed sufficient cash for at least another quarter and noted potential funding options.
- The report contains statutory ASX compliance declarations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$104 |
Notification regarding unquoted securities - ALA
|
16 Jul 2025 8:54AM |
$0.100 |
$0.087 |
fallen by
13%
|
|
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$50 |
dorsaVi's RRAM Performance Metrics in Embedded Systems
|
16 Jul 2025 8:54AM |
$0.024 |
$0.050 |
risen by
108.33%
|
|
DVL - Price-sensitive ASX Announcement
Full Release
Key Points
- dorsaVi Ltd specializes in wearable sensor technology for movement and muscle activity analysis.
- DVL (DorsaVi’s RRAM) provides high-accuracy real-time data for clinical, occupational, and sports applications.
- Metrics are validated and shown to be reliable in both laboratory and real-world embedded system environments.
- Technology is portable, easy to integrate, and supports scalable deployment across multiple use cases.
- Key applications include injury prevention, rehabilitation, workplace risk assessment, and athletic performance optimization.
- Objective, quantitative data from the sensors enhances decision-making for clinicians, therapists, and coaches.
- Emphasis on user-friendly design, robust data management, and secure information handling.
- dorsaVi’s solutions are tailored to meet the performance and operational requirements of embedded systems.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$120 |
Update - Notification of buy-back - TOP
|
16 Jul 2025 8:54AM |
$0.650 |
$0.690 |
risen by
6.15%
|
|
| Challenger Limited (CGF) ORDINARY FULLY PAID |
Financials |
$5,766 |
Change of Director's Interest Notice
|
16 Jul 2025 8:54AM |
$8.210 |
$8.340 |
risen by
1.58%
|
|
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$140 |
Resource Upgrade Diamond Drilling Commenced Tanbreez Project
|
16 Jul 2025 8:53AM |
$0.072 |
$0.097 |
risen by
34.72%
|
|
| Tryptamine Therapeutics Limited (TYP) ORDINARY FULLY PAID |
Health Care |
$47 |
Key appointments strengthen TRP-8803 clinical development
|
16 Jul 2025 8:53AM |
$0.031 |
$0.034 |
risen by
9.68%
|
|
| Li-S Energy Limited (LIS) ORDINARY FULLY PAID |
Industrials |
$102 |
LIS appoints US representative to advance engagement
|
16 Jul 2025 8:52AM |
$0.155 |
$0.160 |
risen by
3.23%
|
|
LIS - Price-sensitive ASX Announcement
Full Release
Key Points
- Li-S Energy Limited (LIS) has appointed a US representative.
- The appointment is aimed at advancing LIS's engagement and presence in the United States.
- This move supports LIS's international expansion and commercialization of lithium-sulfur battery technology.
- The US representative will facilitate partnerships, customer and investor relations, and business development.
- The appointment reflects the increased interest in advanced battery technologies in the US market.
- LIS is committed to building its profile and capitalizing on global opportunities for next-generation energy solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gemlife Communities Group (GLF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,818 |
Acquisition of the initial eight Aliria projects
|
16 Jul 2025 8:46AM |
$4.070 |
$4.780 |
risen by
17.44%
|
|
| WIA Gold Limited (WIA) ORDINARY FULLY PAID |
Materials |
$440 |
Kokoseb Mineral Resource Estimate Update Presentation
|
16 Jul 2025 8:44AM |
$0.265 |
$0.320 |
risen by
20.75%
|
|
WIA - Price-sensitive ASX Announcement
Full Release
Key Points
- WIA Gold Limited released an updated Mineral Resource Estimate for the Kokoseb Gold Project in Namibia.
- The Kokoseb Mineral Resource now stands at 2.1 million ounces at 1.0g/t gold (Au), indicating a 26% increase in contained gold from the previous estimate.
- The resource is entirely in the Inferred category and is constrained by a conceptual open pit.
- The update incorporates results from 163 diamond and reverse circulation holes, totaling 42,366 meters drilled to date.
- Kokoseb's geology is described as a large-scale shear-hosted gold system with consistent gold mineralization.
- Recent drilling has extended the mineralized footprint, with significant intercepts reported at depth and along strike.
- The project is located within the Damaran Gold Project in the Central Damara Belt, a prospective region with established infrastructure and supportive mining jurisdiction.
- WIA Gold Limited is pursuing further exploration, with ongoing drilling and a focus on resource expansion and discovery of nearby prospects.
- Exploration upside is supported by numerous untested targets in proximity to Kokoseb, and further drilling is planned for 2024.
- The presentation outlines a phased development strategy, emphasizing the project's scalability and potential to deliver further resource growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$8 |
High Grade Gallium Intercepts Continue at Caladao Project
|
16 Jul 2025 8:41AM |
$0.100 |
$0.084 |
fallen by
16%
|
|
AXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Axel REE Limited (ASX: AXL) reported continued high-grade gallium and REE intercepts at the Caladao Project in Brazil.
- Recent drilling has expanded the known extent and continuity of gallium and REE mineralization.
- Significant gallium grades reported over large thicknesses, with strong NdPr (neodymium and praseodymium) rare earth values.
- Results support the potential for both gallium and REE extraction from the project.
- Further exploration, metallurgical testing, and resource definition work are planned.
- The Caladao Project benefits from favorable logistics and infrastructure.
- The results reinforce Axel REE Limited’s position in the global critical minerals sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
